Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Osmotic controlled-release oral delivery system"'
Autor:
Purushottam S. Gangane, Debarshi Kar Mahapatra, Rutuja Meshram, Shrinivas Gatlewar, Nilesh M. Mahajan
Publikováno v:
International Journal of Current Research and Review. 12:43-48
Publikováno v:
Clinical Pediatrics. 55:1197-1201
Treatment effectiveness between equivalent doses of non-OROS (osmotic controlled release oral delivery system) methylphenidate ER and OROS methylphenidate ER (brand name Concerta) was examined in a clinical case series of children and adolescents fol
Autor:
Young Hui Yang, Jae Sung Lee, Soo Churl Cho, Dong Soo Lee, Jun-Won Hwang, Hye Jin Kang, Boong Nyun Kim
Publikováno v:
Journal of the Korean Academy of Child and Adolescent Psychiatry. 27:64-71
Publikováno v:
Clinical Neuropharmacology. 38:30-35
OBJECTIVES This study examined the effect of osmotic-controlled release oral delivery system-methylphenidate (OROS-MPH) on the adaptive functioning of children and adolescents with attention-deficit/hyperactivity disorder (ADHD) and investigated the
Autor:
Jeong Seop Lee, Hanik K. Yoo, Hyung Mo Sung, Seong Hye Hwang, Bongseog Kim, Yun Mi Shin, Eui Jung Kim
Publikováno v:
Journal of the Korean Academy of Child and Adolescent Psychiatry. 25:65-72
Objectives:The objective of this study was to evaluate the treatment duration and adherence of osmotic-controlled release oral delivery system (OROS) methylphenidate for treatment of attention-deficit hyperactivity disorder (ADHD). Methods:A total of
Autor:
Hanik K. Yoo, Young-Chul Chung, Dong-Won Shin, Jun-Won Hwang, Myung Ho Lim, Jonghun Lee, Young-Jae Woo, Yeni Kim, Hee-Jeong Yoo, Jeong Seop Lee, Wan Seok Seo, Tae Ho Kim, Bongseog Kim, Chul-Ho Jung
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 28:600-607
Objective The aim of the current study was to investigate the effect of methylphenidate-osmotic release oral delivery system (MPH-OROS) treatment on parenting stress in parents of children and adolescents with attention-deficit/hyperactivity disorder
Publikováno v:
Clinical neuropharmacology. 40(1)
OBJECTIVES Methylphenidate (MPH) treatment in patients with attention-deficit/hyperactivity disorder (ADHD) is reported to reduce the risk for injuries. In the present study, the rate and timing of injuries were compared among the various MPH prepara
Publikováno v:
Current Medical Research and Opinion. 22:1879-1892
The osmotic-controlled release oral delivery system, OROS, is an advanced drug delivery technology that uses osmotic pressure as the driving force to deliver pharmacotherapy, usually once-daily, in several therapeutic areas.The purpose of this review
Publikováno v:
The Journal of Clinical Pharmacology. 40:1141-1149
Methylphenidate hydrochloride (HCl) is frequently used for the treatment of attention deficit/hyperactivity disorder (ADHD). A study was conducted in healthy subjects to evaluate the dose-ranging pharmacokinetics of 18, 36, and 54 mg methylphenidate
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.